FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.